Determination of halofantrine and its main metabolite desbutylhalofantrine in rat plasma by high-performance liquid chromatography with on-line UV irradiation and peroxyoxalate chemiluminescence detection.

A sensitive, selective and reliable method has been developed and validated for the determination of halofantrine and its metabolite desbutylhalofantrine in rat plasma using 9,10-diphenylanthracene as an internal standard. The method is based on peroxyoxalate chemiluminescence detection of hydrogen peroxide produced from fused aromatic rings in the structures of halofantrine and desbutylhalofantrine upon UV irradiation. Using spiked rat plasma, good linear relationships were obtained for both halofantrine and desbutylhalofantrine between peak height ratios (vs internal standard) and their corresponding concentrations over a range of 0.01-0.8 microg/mL with correlation coefficients of at least 0.997. The detection limits at signal-to-noise ratio of 3 using 0.2 mL of rat plasma were 1.5 and 1.4 ng/mL for halofantrine and desbutylhalofantrine, respectively. Relative standard deviations (n = 3) intra- and inter-day were between 0.5 and 5.4% for all the studied concentrations. Using this method with simple sample treatment, halofantrine and desbutylhalofantrine in rat plasma could be precisely determined without interference from endogenous substances. The method was successfully applied to the measurement of the time courses of plasma halofantrine concentration after oral administration of the drug (7 mg/kg) to rats.

[1]  N. Kishikawa,et al.  Determination of aromatic compounds by high-performance liquid chromatography with on-line photoreactor and peroxyoxalate chemiluminescence detection. , 2007, Luminescence : the journal of biological and chemical luminescence.

[2]  Meilin Liu,et al.  Chemiluminescence energy transfer reaction for the on-line preparation of peroxymonocarbonate and Eu(II)-dipicolinate complex. , 2006, The journal of physical chemistry. A.

[3]  G. Scriba,et al.  Analysis of the antimalarial drug halofantrine and its major metabolite N-desbutylhalofantrine in human plasma by high performance liquid chromatography. , 2006, Journal of pharmaceutical and biomedical analysis.

[4]  H. Kristensen,et al.  Comparison of the Lymphatic Transport of Halofantrine Administered in Disperse Systems Containing Three Different Unsaturated Fatty Acids , 2001, Pharmaceutical Research.

[5]  K. Rieckmann,et al.  Pharmacokinetics of halofantrine and n-desbutylhalofantrine in patients with falciparum malaria following a multiple dose regimen of halofantrine , 2004, European Journal of Clinical Pharmacology.

[6]  C. Porter,et al.  Desbutylhalofantrine: Evaluation of QT Prolongation and Other Cardiovascular Effects after Intravenous Administration In Vivo , 2003, Journal of cardiovascular pharmacology.

[7]  N. Kishikawa,et al.  Determination of organic peroxides by liquid chromatography with on-line post-column ultraviolet irradiation and peroxyoxalate chemiluminescence detection. , 2003, Journal of chromatography. A.

[8]  D. Brocks,et al.  The influence of lipids on stereoselective pharmacokinetics of halofantrine: Important implications in food-effect studies involving drugs that bind to lipoproteins. , 2002, Journal of pharmaceutical sciences.

[9]  G. Lefèvre,et al.  Comparison of the cardiac effects of the antimalarials co-artemether and halofantrine in healthy participants. , 2002, The American journal of tropical medicine and hygiene.

[10]  J. Lin,et al.  Luminol chemiluminescence in unbuffered solutions with a cobalt(II)-ethanolamine complex immobilized on resin as catalyst and its application to analysis. , 2001, Analytical chemistry.

[11]  D. Brocks,et al.  Stereoselective pharmacokinetics of desbutylhalofantrine, a metabolite of halofantrine, in the rat after administration of the racemic metabolite or parent drug , 2000, Biopharmaceutics & drug disposition.

[12]  C. Onyeji,et al.  Ion-pair reversed-phase high-performance liquid chromatographic analysis of halofantrine and desbutylhalofantrine in human plasma. , 1997, Therapeutic drug monitoring.

[13]  A. Nagai.  ADVANTAGES OF ON-LINE DEGASSING , 1996 .

[14]  J. Chaulet,et al.  New solid-phase extraction for an improved high-performance liquid chromatographic procedure for the quantitation of halofantrine and monodesbutylhalofantrine in blood or plasma. , 1995, Journal of chromatography. B, Biomedical applications.

[15]  C. Porter,et al.  A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions. , 1995, Journal of pharmaceutical and biomedical analysis.

[16]  J. Le bras,et al.  Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients. , 1994, The American journal of tropical medicine and hygiene.

[17]  G. Blaschke,et al.  Direct determination of the enantiomers of halofantrine and its pharmacologically active metabolite N-desbutylhalofantrine by high-performance liquid chromatography. , 1993, Journal of chromatography.

[18]  H. Webster,et al.  Halofantrine given with food for falciparum malaria. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  S. Ward,et al.  Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria. , 1991, British journal of clinical pharmacology.

[20]  P. Camilleri,et al.  Fluorescence detection of the enantiomers of halofantrine at picomole levels using chiral high-performance liquid chromatography , 1990 .

[21]  K. Imai,et al.  Synthesis of pyrimido[5,4-d]pyrimidine derivatives and their ultraviolet absorption and fluorescence spectral properties , 1990 .

[22]  A. Breckenridge,et al.  Pharmacokinetics of halofantrine in man: effects of food and dose size. , 1989, British journal of clinical pharmacology.

[23]  G. Edwards,et al.  Determination of halofantrine and its principal metabolite desbutylhalofantrine in biological fluids by reversed-phase high-performance liquid chromatography. , 1988, Journal of chromatography.

[24]  U. Brinkman.  A review of reaction detection in HPLC , 1987 .

[25]  C. Cook,et al.  Paired-ion liquid chromatographic method for the analysis of a phenanthrenemethanol antimalarial in whole blood. , 1985, Journal of pharmaceutical sciences.

[26]  J. Sekino,et al.  Application of high-performance liquid chromatography with a chemiluminescence detection system to determine catecholamines in urine. , 1981, Analytical biochemistry.

[27]  Kazuhiro Imai,et al.  Determination of fluorescent compounds by high performance liquid chromatography with chemiluminescence detection , 1980 .

[28]  G. Schuster.  Chemiluminescence of organic peroxides. Conversion of ground-state reactants to excited-state products by the chemically initiated electron-exchange luminescence mechanism , 1979 .